An Overview of Humacyte's Earnings

Humacyte HUMA is gearing up to announce its quarterly earnings on Monday, 2025-08-11. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Humacyte will report an earnings per share (EPS) of $-0.17.

Anticipation surrounds Humacyte's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Performance in Previous Earnings

Last quarter the company beat EPS by $0.09, which was followed by a 8.09% increase in the share price the next day.

Here's a look at Humacyte's past performance and the resulting price change:

Market Performance of Humacyte's Stock

Shares of Humacyte were trading at $2.47 as of August 07. Over the last 52-week period, shares are down 61.91%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Humacyte visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.